Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular diversity in isocitrate dehydrogenase-wild-type glioblastoma

1 Jan 2024

Abstract excerpt

Abstract In the dynamic landscape of glioblastoma, the 2021 World Health Organization Classification of Central Nervous System tumours endeavoured to establish biological homogeneity, yet isocitrate dehydrogenase-wild-type (IDH-wt) glioblastoma persists as a tapestry of clinical and molecular diversity. Intertumoural heterogeneity in IDH-wt glioblastoma presents a formidable challenge in treatment strategies....

Topics

Join the communities discussing this publication.

Cancer, Hypoxia, and Metabolism
Glioma Diagnosis and Treatment
MicroRNA in disease regulation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38646145
DOI: 10.1093/braincomms/fcae108

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular diversity in isocitrate dehydrogenase-wild-type glioblastomaPMID 38646145Read ↗

Isocitrate dehydrogenase mutations in defining the biology of and supporting clinical decision making in glioblastoma.Semantic proximity Read ↗

Genetic evolution and cellular interactions within the tumour microenvironment determine glioblastoma progressionSemantic proximity Read ↗

Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implicationsSemantic proximity Read ↗

Immune landscape of isocitrate dehydrogenase stratified human gliomasSemantic proximity Read ↗

The Hallmarks of Glioblastoma: Heterogeneity, Intercellular Crosstalk and Molecular Signature of Invasiveness and ProgressionSemantic proximity Read ↗

Multiregional Sequencing of IDH-WT Glioblastoma Reveals High Genetic Heterogeneity and a Dynamic Evolutionary HistorySemantic proximity Read ↗

Glioblastoma: Changing concepts in the WHO CNS5 classification.Semantic proximity Read ↗

Genetic Hallmarks and Heterogeneity of Glioblastoma in the Single‐Cell Omics EraSemantic proximity Read ↗

Beyond the World Health Organization classification of central nervous system tumors 2016: what are the new developments for gliomas from a clinician's perspective?Semantic proximity Read ↗

New hints towards a precision medicine strategy for IDH wild-type glioblastoma.Semantic proximity Read ↗

Histological and molecular glioblastoma, IDH-wildtype: a real-world landscape using the 2021 WHO classification of central nervous system tumorsSemantic proximity Read ↗

Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.